Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy (VOCAL)

Investigator: Aparna Kamat, MD

Study Coordinator: Jaya Kamath

Status: Enrolling Number: NCT03837327

Phone: 713.441.6616

Protocol Number: Pro00022956


The purpose of this study is to prospectively collect de-identified biological samples and data from women with a known pelvic mass, in order to validate ovarian cancer specific glycoproteomic signatures in the blood based on histologically confirmed malignancy status of the mass.
More to Explore